Chartwell Investment Partners, LLC Relmada Therapeutics, Inc. Transaction History

Chartwell Investment Partners, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 09, 2021	SELL	$29.88 - $39.8 $218,960 - $291,654	-7,328 Closed	0 $0
Q2 2020 Jul 29, 2020	SELL	$31.59 - $49.98 $68,044 - $107,656	-2,154 Reduced 22.72%	7,328 $328,000
Q1 2020 Apr 30, 2020	BUY	$23.78 - $50.12 $16,693 - $35,184	702 Added 8.0%	9,482 $323,000
Q4 2019 Jan 29, 2020	BUY	$10.1 - $47.18 $88,678 - $414,240	8,780 New	8,780 $342,000

8.32M

364K

46.5K

Ticker RLMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,608,500
Market Cap $8.58M
Description
Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing various products for the treatment of central nervous system (CNS) diseases and other disorders. Its lead product candidate is Esmethadone (d-methadone, dextromethadone, and REL-1017), a new chemical entity and N-methyl-D-aspartate receptor antagonist that ...

Get notified when there are updates to the investment portfolio of Chartwell Investment Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Chartwell Investment Partners, LLC with notifications on news.